Ultime notizie per Quanterix (NASDAQ:QTRX) Azioni

Quanterix

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

News

Faraday Future Intelligent Electric Inc. - Class A Common Stock

FFAI

Reported Earlier, Faraday Future Capitol Hill Event On July 23 To Emphasize Role Of U.S. Policy In Advancing The Future Of AI-Driven Electric Vehicles

<ul>
<li>Neurizon&#xAE; Therapeutics and Elanco Animal Health&nbsp;enter into an exclusive global licensing agreement</li>
<li>Provides worldwide rights&nbsp;for Neurizon to utilise Elanco's intellectual property, providing exclusive access to an extensive package of non-clinical studies and manufacturing data and outlines&nbsp;key terms for a future supply agreement for GMP-compliant Monepantel</li>
<li>Provides a&nbsp;clear pathway for accelerated global commercialisation&nbsp;of NUZ-001[1] and significantly&nbsp;de-risks future global regulatory approval processes</li>
<li>The license agreement represents the&nbsp;first step in formalising Neurizon's relationship with Elanco, with the&nbsp;next step focused on finalising a supply agreement expected H2 CY 2025</li>
</ul>

ELAN

Reported Earlier, Neurizon And Elanco Execute Strategic Licensing Deal To Provide Clear Pathway For Accelerated Global Commercialisation Of NUZ-001

WENNU

Reported Earlier, Wen Acquisition Corp Announces Commencement Of Separate Trading Of Class A Ordinary Shares And Warrants On July 7, 2025

SNPS

Reported Earlier, Synopsys Issues Official Statement On Rescinded US Export Controls And Ongoing China Market Assessment

<ul>
<li>Offer of US$3.01 in cash plus one contingent value right for potential additional aggregate payments of up to US$1.19 per share</li>
<li>Upfront and total potential cash consideration represent respectively a 126% and 216% premium to Nasdaq closing price on date prior to announcement of Future Pak's initial non-binding proposal</li>
<li>Transaction with Future Pak represents culmination of sale process whereby Theratechnologies solicited interest from a number of potential counterparties</li>
<li>Board unanimously recommends that shareholders approve the transaction</li>
</ul>
 &nbsp;

THTX

Reported Earlier, Theratechnologies Enters Definitive Agreement To Be Acquired By CB Biotechnology For $3.01 Per Share Plus Contingent Value Right

Despite the economic downturn in China, former IMF Chief Economist Kenneth Rogoff believes the country's push to undermine the U.S. dollar's global dominance remains firmly on track.
What Happened: On Wednesday, Rogoff replied &#8220;absolutely&#8221; when asked about China gaining traction in challenging the dollar&#8217;s supremacy, despite a slowing domestic economy, while speaking on The Call, a podcast by the U.S. Chamber of Commerce.
According to Rogoff, Beijing's efforts extend far beyond currency peg adjustments, which he says China has been doing far more aggressively over the past decade, especially following Western sanctions on Russia.
The broader strategy, Rogoff says, involves building independent financial infrastructure, including alternative settlement and clearing systems, to reduce reliance on the U.S.-dominated network. &#8220;To truly break away, China wants transactions in yuan and control over how they're settled,&#8221; he said.
See Also: <a href="https://www.benzinga.com/content/46218202/dollar-down-10-these-3-stocks-could-soar">Dollar Down 10%? These 3 Stocks Could Soar</a>
Even with China's real estate crisis and declining growth, Rogoff argues those macro headwinds don't necessarily derail Beijing's strategic objectives.
&#8220;China doesn't have to grow at 7% in order to establish the yuan as more of a currency,&#8221; he said. &#8220;They're the world's largest trading partner for probably more than half the countries in the world. So they're there. They've arrived.&#8221;
Rogoff draws parallels to Japan's post-boom era, warning that China is repeating many of the same mistakes, including significantly overinvesting in real estate and infrastructure. Yet despite that, he insists the yuan can continue gaining ground regionally.
He also warns that the U.S. is accelerating its own decline. &#8220;The erosion of the dollar, which I argue started a decade ago, is accelerating,&#8221; Rogoff said, citing trade policies and erratic decision-making in Washington as contributing factors.
Why It Matters: Rogoff had mentioned the same thing in an interview a week ago, warning of the consequences of &#8216;de-dollarization,&#8217; while saying that <a href="https://www.benzinga.com/real-estate/25/06/46115111/americans-are-not-prepared-says-harvard-economist-about-chinas-de-dollarization-interest-rates-are-going-to-be-higher-for-a-very-very-long-time">most Americans are unprepared</a> for such an eventuality.
&#8220;It&#8217;s going to put pressure on the U.S. budget, interest rates, and Americans are not prepared for any of that,&#8221; Rogoff said.
Several other prominent experts and analysts have cautioned about the same, with Adam Turnquist, a chief technical strategist at LPL Financial, warning of <a href="https://www.benzinga.com/markets/forex/25/06/45943600/is-us-dollar-losing-its-edge-de-dollarization-and-fading-exceptionalism-raise-alarms">further downside risks</a> for the greenback, following a sharp decline since the beginning of 2025.
According to Turnquist, &#8220;The dollar is also contending with recently renewed tariff threats, an ongoing de-dollarization theme, and fading enthusiasm for American exceptionalism.&#8221;
Chatham House expert, David Lubin, noted two months ago that some people within the Trump administration may view the <a href="https://www.benzinga.com/government/regulations/25/04/44858165/policy-push-vs-market-pull-dollar-under-pressure-as-reserve-currency-may-be-called-into-question-amid-tariff-turmoil">reserve status of the U.S. Dollar</a> as &#8220;more of a burden to the U.S. economy than a blessing.&#8221;
The U.S. Dollar Index (DXY) currently trades at 96.844 against a basket of other currencies, up slightly by 0.07% on Thursday. The currency is down 11.44% since January 20, since the Trump Administration came to power.
Photo Courtesy: FOTOGRIN on Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/06/46171994/emerging-markets-stocks-dollar-outlook">A Weaker Dollar Just Unlocked A Surprise 2025 Winner — And Smart Money Is Moving In</a></li>
</ul>

Asia

Government

Markets

Dollar Supremacy Under Threat Despite A Slowing China? 'Absolutely,' Says This Economist — Beijing Is The Largest Trading Partner For Half The World And They've 'Arrived'

<ul>
<li>The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1</li>
<li>Safety in GCA patients was consistent with known safety profile of Cosentyx&#xAE; (secukinumab)1</li>
</ul>

Novartis Reports Phase III GCAptAIN Study Did Not Meet Primary Endpoint Of Sustained Remission At Week 52 In GCA Patients

MIRA Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) shares soared to $1.87, an approximate 50.8% jump, during after-hours trading on Wednesday.
What Happened: After the announcement of Mira-55, a synthetic analog of marijuana, providing pain relief comparable to morphine, the stock value of MIRA Pharmaceutical exploded, signaling an aggressive investor buying.
Mira-55, engineered to selectively activate CB2 receptors, displayed minimal activity at CB1 receptors, thus avoiding psychoactive side effects. In a formalin-based rodent model, the drug significantly reduced pain sensitivity and showed efficacy comparable to morphine, without any sedative or inflammatory effects.
See Also: <a href="https://benzinga.com/crypto/cryptocurrency/25/07/46215827/bitcoins-halving-cycle-is-over-standard-chartered-affirms-what-that-means-for-you">Bitcoin&#8217;s Halving Cycle Is &#8216;Over&#8217;, Standard Chartered Affirms: What That Means For You</a>
The U.S. Drug Enforcement Administration (DEA) has confirmed that Mira-55 is not a controlled substance, removing a significant regulatory barrier to its clinical development. The company is now advancing Mira-55 towards an Investigational New Drug (IND) submission, with development efforts supporting future clinical trials in inflammatory pain indications.
Chairman and CEO of MIRA,&nbsp; Erez Aminov noted, "With Mira-55 and Ketamir-2, we believe we're building a differentiated, non-opioid pain franchise with the potential to treat two of the largest and most underserved pain markets,"&nbsp;
Why It Matters: The promising results of Mira-55 is an advancement for MIRA Pharmaceuticals, which has been making strides in the pain management sector. In May, the company&#8217;s lead program, Ketamir-2, <a href="https://www.benzinga.com/general/biotech/25/05/45217506/exclusive-mira-pharmaceuticals-lead-program-ketamir-2-shows-no-brain-toxicity-in-fda-mandated-study">showed no brain toxicity</a> in an FDA-mandated study. This was followed by the company&#8217;s announcement in March that it was expanding its pain management portfolio with the formulation of Ketamir-2 as a topical treatment for localized neuropathic and inflammatory pain.
Furthermore, MIRA Pharmaceuticals&#8217; acquisition of SKNY Pharmaceuticals, the developer of SKNY-1, a novel investigational therapy targeting obesity and nicotine addiction, is also <a href="https://www.benzinga.com/general/biotech/25/05/45281398/exclusive-mira-pharmaceuticals-board-approves-skny-pharma-acquisition-establishing-combined-enterprise-value-over-60-million">expected to enhance its value proposition</a>. The company&#8217;s announcement in June that SKNY-1 demonstrated a 30% reduction in body weight without muscle loss, along with a reversal of nicotine cravings, further supported the advancement of SKNY-1 toward Investigational New Drug (IND) 
Price Action: According to <a href="https://www.benzinga.com/quote/MIRA">Benzinga Pro</a> data, MIRA Pharmaceuticals stock closed at $1.24, up 2.48% but soared to $1.87 with a massive spike of 50.81% during after-hours trading.
Benzinga&#8217;s Edge Stock Rankings indicates MIRA Pharmaceuticals with a momentum of 91.78 shows high recent price strength. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-3/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Find out</a> the stock value of pharmaceutical companies.enabling studies.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="871" height="159" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03011705/Screenshot-2025-07-03-104648.png" alt="" class="wp-image-971362" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03011705/Screenshot-2025-07-03-104648.png 871w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03011705/Screenshot-2025-07-03-104648-300x55.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03011705/Screenshot-2025-07-03-104648-768x140.png 768w" sizes="(max-width: 871px) 100vw, 871px" /></figure>
Read Next: <a href="https://benzinga.com/news/financing/25/07/46215975/trumps-big-beautiful-bill-offers-seniors-a-6000-bonus-tax-deduction-heres-how-you-qualify-for-the-">Trump&#8217;s &#8216;Big, Beautiful Bill&#8217; Offers Seniors A $6,000 &#8216;Bonus&#8217; Tax Deduction: Here&#8217;s How You Qualify For The Benefit</a>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Photo Courtesy: Martin Gregor on Shutterstock.com

Health Care

MIRA

MIRA Pharmaceuticals'  Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours

Anduril Industries CEO Palmer Luckey disclosed Wednesday that his company&#8217;s autonomous weapons systems have destroyed &#8220;hundreds of millions&#8221; worth of Russian military assets in Ukraine, while advocating for increased U.S. military support as the fastest path to peace.
What Happened: &#8220;Anduril had people/hardware in Ukraine two weeks into the invasion. Our autonomous weapons have destroyed hundreds of millions worth of Russia&#8217;s war machine,&#8221; Luckey wrote on X. &#8220;The United States should give them the tools they need to win. It is the fastest path to peace, one way or another.&#8221;
The statement came in response to Ukrainian presidential aide Andriy Yermak, who praised Luckey&#8217;s early support during the conflict. Yermak described the defense tech executive as &#8220;steady, kind, and clear&#8221; in a wartime meeting.
Anduril&#8217;s involvement in Ukraine comes as global defense <a href="https://www.benzinga.com/25/04/45032800/global-defense-budgets-surge-to-27-trillion-as-europe-and-middle-east-lead-steepest-increase-since-cold-war-report">spending surged 9.4% to $2.72 trillion in 2024</a>, according to Stockholm International Peace Research Institute data. The increase marks the steepest annual rise since the Cold War, with Europe and the Middle East leading expenditure growth.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Anduril had people/hardware in Ukraine two weeks into the invasion. Our autonomous weapons have destroyed hundreds of millions worth of Russia&#39;s war machine. The United States should give them the tools they need to win. It is the fastest path to peace, one way or another. <a href="https://t.co/V5dO1kYjTV">https://t.co/V5dO1kYjTV</a>
&mdash; Palmer Luckey (@PalmerLuckey) <a href="https://twitter.com/PalmerLuckey/status/1940600367823347934?ref_src=twsrc%5Etfw">July 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/events/25/07/46238524/pentagon-says-us-strikes-set-back-irans-nuclear-program-by-2-years-after-b-2-bombers-hit-fordo-natanz-and-esfahan">Pentagon Says US Strikes Set Back Iran&#8217;s Nuclear Program By 2 Years After B-2 Bombers Hit Fordo, Natanz And Esfahan</a>
Why It Matters: The Southern California-based defense contractor recently <a href="https://www.benzinga.com/markets/market-summary/25/06/45810158/anduril-raises-2-5-billion-at-30-5-billion-valuation-doubling-in-a-year-as-defense-contracts-grow">raised $2.5 billion at a $30.5 billion valuation</a>, more than doubling from last year&#8217;s $14 billion mark. Founders Fund, backed by billionaire Peter Thiel, led the round with a record $1 billion commitment.
Luckey confirmed the <a href="https://www.benzinga.com/markets/ipos/25/06/45877601/anduril-ceo-palmer-luckey-confirms-ipo-plans-to-compete-for-trillion-dollar-defense-contracts-we-are-definitely-going-to-be-a-publicly-traded">company plans to go public</a>, stating &#8220;there&#8217;s not really a path to a company like Anduril winning things in the shape of let&#8217;s say a trillion dollar F-35 joint strike fighter contract as a private company.&#8221;
The disclosure comes amid ongoing peace negotiations between Russia and Ukraine, with President Donald Trump threatening &#8220;large-scale&#8221; sanctions on Moscow unless progress is made. The U.S. recently signed a mineral resources agreement with Ukraine, granting American companies priority <a href="https://www.benzinga.com/25/03/45128890/trump-and-zelensky-sign-the-mineral-resource-deal">access to Ukrainian critical minerals</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46233559/alexandria-ocasio-cortez-bashes-trump-no-tax-on-tips-bill-provision-as-scam" target="_blank" rel="noreferrer noopener">Alexandria Ocasio-Cortez Bashes Trump's ‘No Tax On Tips' Bill Provision As ‘Scam'</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Tada Images / Shutterstock.com

Anduril CEO Palmer Luckey Says Weapons Destroyed 'Hundreds of Millions' in Russian Assets, Urges US Military Aid to Ukraine

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) stock surged on Wednesday as the EV giant reported Q2 2025 delivery figures more or less in line with Wall Street estimates amid <a href="https://www.benzinga.com/markets/tech/25/06/46087914/teslas-europe-sales-slide-for-5th-straight-month-elon-musk-led-ev-giants-market-share-shrinks-to-1-3">declining sales</a> and CEO Elon Musk's <a href="https://www.benzinga.com/news/politics/25/07/46216023/after-trump-warns-elon-musk-to-close-up-shop-china-rallies-behind-worlds-richest-man-theres-no-need-to-keep-putting-up-with-it">feud with U.S. President</a> Donald Trump.
What Happened: Tesla delivered 384,122 vehicles in Q2, with the majority of the number coming from the Tesla Model 3 and the Model Y, according to a press release shared by the company on Wednesday.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> (+4.4% pre-mkt) reported 2Q deliveries of 384K -14% YoY and roughly in line with WS consensus. This was much better than feared low estimates of 355K-360K. As we indicated yesterday, this is likely to be a buy-the-news event. <a href="https://t.co/YTTD2lUKgh">https://t.co/YTTD2lUKgh</a> <a href="https://t.co/UIulYp4bI0">https://t.co/UIulYp4bI0</a>
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1940402335546785915?ref_src=twsrc%5Etfw">July 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Veteran investor Gary Black explained in a post on social media platform X on Wednesday what could've driven Tesla's better-than-estimated performance. "$TSLA now +4.3% on better than feared 2Q deliveries," he said in the post.
Black added that Tesla beat the 370k estimate predicted by him, "2Q was better than expected, led by refreshed Model Y delivs and strong quarter-end China deliveries," he said.
The investor noted that the strong delivery figures could lead to positive revisions in the company&#8217;s 2025 delivery estimates, "especially with the planned elimination of the $7,500 EV credit in Trump's tax and spending bill."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24TSLA&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$TSLA</a> now +4.3% on better than feared 2Q deliveries. If one just reads the headlines, one would think TSLA missed. Versus my 370K estimate (higher than most here on X), 2Q was better than expected, led by refreshed Model Y delivs and strong quarter-end China deliveries. This… <a href="https://t.co/oorXAtMF7w">pic.twitter.com/oorXAtMF7w</a>
&mdash; Gary Black (@garyblack00) <a href="https://twitter.com/garyblack00/status/1940449192461091176?ref_src=twsrc%5Etfw">July 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: The stock surge led by the figures could provide relief to Tesla, which has been grappling with poor sales in markets like Sweden and Norway, where sales <a href="https://www.benzinga.com/markets/tech/25/07/46189042/elon-musk-led-teslas-european-woes-worsen-with-sales-down-over-60-in-sweden-and-denmark">declined more than 60%</a>.
Tesla's <a href="https://www.benzinga.com/markets/tech/25/06/46162850/tesla-sales-in-canada-have-dropped-to-nearly-zero-says-researcher-expects-elon-musk-led-ev-giant-may-report-losses-starting-2026">Canadian sales </a><a href="https://www.benzinga.com/markets/tech/25/06/46162850/tesla-sales-in-canada-have-dropped-to-nearly-zero-says-researcher-expects-elon-musk-led-ev-giant-may-report-losses-starting-2026" target="_blank" rel="noopener">also took a hit,</a> with some researchers suggesting that the EV giant's sales are "close to zero" in the country. The declining sales could be attributed to Musk's right-wing political views and close association with Trump.
Interestingly, Musk is said to <a href="https://www.benzinga.com/markets/tech/25/07/46214467/elon-musk-will-oversee-tesla-sales-in-the-us-europe-after-omead-afshars-exit-report">oversee Tesla sales</a> in the U.S. and Europe himself after close aide Omead Afshar's <a href="https://www.benzinga.com/markets/tech/25/06/46132042/teslas-q2-sales-going-to-s-says-gary-black-after-tsla-north-america-and-europe-chief-omead-afshars-exit">departure from Tesla</a>, with SVP Tom Zhu said to oversee global production operations.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="198" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001011/TSLA-JUL-3-2205-1024x198.jpg" alt="" class="wp-image-971308" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001011/TSLA-JUL-3-2205-1024x198.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001011/TSLA-JUL-3-2205-300x58.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001011/TSLA-JUL-3-2205-768x148.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001011/TSLA-JUL-3-2205-1536x297.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001011/TSLA-JUL-3-2205.jpg 1554w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Tesla offers satisfactory Momentum and Quality, while scoring well on the Growth metric, but the stock offers poor Value. For more such insights, sign up for<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"> Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga's Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46212611/gary-black-says-teslas-q2-deliveries-could-be-a-buy-the-news-event-i-believe-tsla-will-miss">Gary Black Says Tesla's Q2 Deliveries Could Be A ‘Buy The News' Event: ‘I Believe TSLA Will Miss'</a></li>
</ul>
Photo courtesy: Ken Wolter / Shutterstock.com

Tech

TSLA

TSLA Stock Surges 5% As Q2 Deliveries 'Better Than Feared:' Gary Black Explains Why Elon Musk-Led Tesla Fared Better Than Market's Worst Fears

Macro Economic Events

Econ #s

Economics

Reported Earlier, China Caixin Services Purchasing Managers Index For June 50.6 Vs. 51.0 Est.; 51.1 Prior

Reported Earlier, Australia Trade Balance For May 2.238B Vs. 5.080B Est.; 4.859B (Revised) Prior

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, au Jibun Bank Japan Services Purchasing Managers' Index For June 51.7 Vs. 51.5 Est.; 51.0 Prior

The Pentagon said on Wednesday that U.S. strikes on Iranian nuclear facilities have degraded Iran&#8217;s nuclear program by up to two years, marking a significant escalation in the assessment of the military operation&#8217;s impact.
What Happened: Pentagon spokesman Sean Parnell told reporters the official estimate was &#8220;probably closer to two years,&#8221; though he provided no evidence to support the assessment. &#8220;We have degraded their program by one to two years, at least intel assessments inside the Department (of Defense) assess that,&#8221; Parnell said.
The strikes occurred on June 22 when U.S. B-2 stealth bombers made by Northrop Grumman Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>) <a href="https://www.benzinga.com/news/politics/25/06/46162332/iran-demands-us-guarantee-of-no-further-strikes-before-nuclear-talks-resume-are-we-going-to-see-a-repetition">targeted three Iranian nuclear facilities</a> at Fordo, Natanz, and Isfahan.
The Pentagon&#8217;s assessment contradicts earlier leaked Defense Intelligence Agency estimates suggesting the strikes only delayed Iran&#8217;s program by months. Secretary of State Marco Rubio defended the operation&#8217;s effectiveness, saying the destruction of <a href="https://www.benzinga.com/news/politics/25/06/46132996/marco-rubio-says-everything-under-the-mountains-is-in-bad-shape-rubbishes-claim-trump-strikes-only-bought-iran-time">Iran&#8217;s conversion facility at Esfahan was decisive</a>. &#8220;Everything underneath that mountain is in bad shape,&#8221; Rubio said.
See Also: <a href="https://www.benzinga.com/news/politics/25/07/46238084/ex-obama-treasury-secretary-jack-lew-sounds-alarm-on-nyc-under-zohran-mamdani-i-worry-deeply">Ex-Obama Treasury Secretary Jack Lew Sounds Alarm On NYC Under Zohran Mamdani: &#8216;I Worry Deeply&#8217;</a>
Why It Matters: The strikes followed a 12-day Israel-Iran conflict that began June 13 when Israel targeted Iranian nuclear sites, claiming Tehran was close to building nuclear weapons. Iran responded with missile attacks <a href="https://www.benzinga.com/news/politics/25/06/46162332/iran-demands-us-guarantee-of-no-further-strikes-before-nuclear-talks-resume-are-we-going-to-see-a-repetition">before direct U.S. intervention</a>.
Central Intelligence Agency Director John Ratcliffe confirmed the strikes &#8220;severely damaged&#8221; Iran&#8217;s nuclear program, citing &#8220;credible evidence&#8221; of <a href="https://www.benzinga.com/news/politics/25/06/46107752/trump-announces-iran-nuclear-talks-following-us-strikes-that-severely-damaged-iranian-nuclear-program">destroyed key facilities</a>. However, International Atomic Energy Agency head Rafael Grossi said Iran could restart uranium enrichment within &#8220;a matter of months.&#8221;
Markets responded positively to ceasefire prospects. Wedbush Securities analyst <a href="https://www.benzinga.com/news/politics/25/06/46162332/iran-demands-us-guarantee-of-no-further-strikes-before-nuclear-talks-resume-are-we-going-to-see-a-repetition">Dan Ives </a>called the Iran-Israel ceasefire &#8220;the most bullish outcome&#8221; for Wall Street, <a href="https://www.benzinga.com/news/politics/25/06/46162332/iran-demands-us-guarantee-of-no-further-strikes-before-nuclear-talks-resume-are-we-going-to-see-a-repetition">predicting 2-3% gains for major indices</a>.
Iran&#8217;s Deputy Foreign Minister Majid Takht-Ravanchi told the BBC that the U.S. must guarantee no additional military strikes before <a href="https://www.benzinga.com/news/politics/25/06/46162332/iran-demands-us-guarantee-of-no-further-strikes-before-nuclear-talks-resume-are-we-going-to-see-a-repetition">Tehran will resume nuclear negotiations</a>. Iranian Ambassador to the UN Amir-Saeid Iravani separately told CBS that uranium enrichment will &#8220;never stop,&#8221; citing it as an &#8220;inalienable right&#8221; under the Nuclear Non-Proliferation Treaty.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46233559/alexandria-ocasio-cortez-bashes-trump-no-tax-on-tips-bill-provision-as-scam">Alexandria Ocasio-Cortez Bashes Trump&#8217;s &#8216;No Tax On Tips&#8217; Bill Provision As &#8216;Scam&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Mike Mareen / Shutterstock.com

Pentagon Says US Strikes Set Back Iran's Nuclear Program By 2 Years After B-2 Bombers Hit Fordo, Natanz And Esfahan

Datadog Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) saw a surge of nearly 11% in its stock value during after-hours trading on Wednesday. What Happened: Datadog&#8217;s stock price experienced a 10.88% increase after the market closed on Wednesday, reaching $149.70. This surge followed the company&#8217;s announcement of its inclusion in the S&amp;P 500 index. The stock&#8217;s closing price was $135.01, reflecting a 2.03% increase during regular trading hours.
S&amp;P Dow Jones announced on July 2, 2025, Datadog is set to join the S&amp;P 500. Datadog<a href="https://www.benzinga.com/trading-ideas/movers/25/07/46236303/datadog-stock-surges-on-sp-500-inclusion"> will officially </a>replace Juniper Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNPR#NYSE">JNPR</a>), acquired by Hewlett-Packard Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>), in the index. This change will be effective before the market opens on July 9, 2025.
See Also: <a href="https://benzinga.com/markets/equities/25/07/46187311/trump-says-elon-musk-would-close-up-shop-and-head-back-home-to-south-africa-without-subsidies-no">Trump Says Elon Musk Would &#8216;Close Up Shop And Head Back Home To South Africa&#8217; Without Subsidies: &#8216;No More Rocket Launches, Satellites, Or Electric Car&#8217;</a>
Datadog&#8217;s market cap is currently at $46.63 billion, with an average trading volume of 4.36 million. The company&#8217;s price-to-earnings ratio stands at 267.48.
Why It Matters: Datadog&#8217;s stock surge comes on the heels of a strong performance in the first quarter of 2025. The company&#8217;s <a href="https://www.benzinga.com/news/earnings/25/05/45221686/datadog-tops-q1-estimates-raises-revenue-outlook-flags-margin-pressure">first-quarter revenue</a> exceeded expectations, increasing by 25% year-over-year to $761.55 million. This performance led to a rise in the company&#8217;s revenue outlook, despite concerns about margin pressure.
Furthermore, a report by BofA Securities suggests that <a href="https://www.benzinga.com/markets/large-cap/25/06/45755544/rising-ai-analytics-budgets-could-lift-microsoft-snowflake-datadog">AI and analytics budgets are on the rise</a>, which could potentially benefit companies like Datadog. The report indicates that while software spending growth intentions have slightly decreased, they are still expected to increase by 9.9% for 2025 and 10.8% for 2026.
Price Action: DDOG stock is closed up at 2.03% at $135.01 during regular trading hours on July 3, 2025.
Benzinga's Edge Stock Rankings indicate a high growth score of 95.78  and bullish trends across all timeframes. Know the <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">other parameters</a> on which the stock fares.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-4/#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="878" height="152" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001036/Screenshot-2025-07-03-092357.png" alt="" class="wp-image-971309" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001036/Screenshot-2025-07-03-092357.png 878w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001036/Screenshot-2025-07-03-092357-300x52.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/03001036/Screenshot-2025-07-03-092357-768x133.png 768w" sizes="(max-width: 878px) 100vw, 878px" /></a></figure>
Photo Courtesy: MacroEcon on Shutterstock.com
Read Next: 
<ul class="wp-block-list">
<li><a href="https://benzinga.com/crypto/25/07/46211872/bitcoin-ethereum-dogecoin-mirror-tech-stocks-sell-off-as-trumps-big-beautiful-bill-passes-senate-analyst-spots-rare-warning-for-btc">Bitcoin, Ethereum, Dogecoin Mirror Tech Stocks Sell-Off As Trump&#8217;s &#8216;Big Beautiful Bill&#8217; Passes Senate: Analyst Spots &#8216;Rare Warning&#8217; For BTC </a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: <a href="http://shutterstock.com">Shutterstock.com</a>

Equities

DDOG

JNPR

Datadog Stock Surges 11% After Hours After Making S&P 500 Debut

Shares of managed care provider Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>) dropped over 40% on Wednesday, marking the worst single-day performance in the company's history.
Check out the current price of&nbsp;<a href="https://www.benzinga.com/quote/CNC" target="_blank" rel="noreferrer noopener">CNC stock here.</a>
What Happened: On CNBC&#8217;s Mad Money, Jim Cramer referred to the collapse as &#8220;a huge hit,&#8221; resulting from a combination of factors such as weak Affordable Care Act enrollments, an actuarial report pointing to sicker patients, and the company&#8217;s decision to <a href="https://www.benzinga.com/markets/guidance/25/07/46209736/centene-withdraws-2025-guidance-shares-dive">pull its 2025 outlook</a>.
&#8220;Companies make forecasts, they&#8217;re supposed to try and beat them,&#8221; Cramer says, however, &#8220;they rarely pull them.&#8221;
According to Cramer, Centene disclosed data from an independent actuarial firm covering 22 of the 29 states where it operates ACA exchange plans.
See Also: <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46195080/doj-dismantles-14-billion-healthcare-fraud-scheme-in-largest-ever-crackdown-impacting-over-1-million-americans">DOJ Dismantles $14 Billion Healthcare Fraud Scheme In Largest-Ever Crackdown, Impacting Over 1 Million Americans</a>
The findings showed that overall marketplace enrollment growth was lower than expected and that those who did enroll were in poorer health than projected, a combination that significantly affects the company's bottom line, thus prompting the company to pull its guidance.
As a result, the company now expects a $1.8 billion reduction in its projected risk adjustment revenue from the federal government. This drop is expected to slash its 2025 earnings by $2.75 per share.
&#8220;This is horrifying,&#8221; Cramer said, referring to the sharp revision in Centene&#8217;s EPS, from $7.25 per share projected earlier. &#8220;We&#8217;re talking about a 35% to 40% hit to their numbers,&#8221; Cramer says, &#8220;no wonder the stock was eviscerated.&#8221;
Why It Matters: Centene&#8217;s decision to withdraw its guidance, citing the independent actuarial report, led to a sector-wide selloff on Wednesday. 
All of Centene&#8217;s peers and competitors in the managed care business, such as Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>), Elevance Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>), UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>), and Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>), among others, all falling in tandem during the day. 
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Stocks / ETFs</td>
<td class="has-text-align-center" data-align="center">1 Day</td>
<td class="has-text-align-center" data-align="center">Year-To-Date</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Centene Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNC#NYSE">CNC</a>)</td>
<td class="has-text-align-center" data-align="center">-40.37%</td>
<td class="has-text-align-center" data-align="center">-44.17%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Molina Healthcare Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOH#NYSE">MOH</a>)</td>
<td class="has-text-align-center" data-align="center">-21.97%</td>
<td class="has-text-align-center" data-align="center">-16.79%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Elevance Health Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>)</td>
<td class="has-text-align-center" data-align="center">-11.50%</td>
<td class="has-text-align-center" data-align="center">-4.26%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>)</td>
<td class="has-text-align-center" data-align="center">-5.70%</td>
<td class="has-text-align-center" data-align="center">-39.04%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>)</td>
<td class="has-text-align-center" data-align="center">-4.19%</td>
<td class="has-text-align-center" data-align="center">+16.72%</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">iShares US Healthcare Providers ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHF#NYSE">IHF</a>)</td>
<td class="has-text-align-center" data-align="center">-6.27%</td>
<td class="has-text-align-center" data-align="center">-3.16%</td>
</tr>
</tbody>
</table>
</figure>
This comes amid a potential amendment in the Affordable Care Act, which could lead to an additional $313 billion in <a href="https://www.benzinga.com/markets/macro-economic-events/25/06/46163659/senate-republicans-propose-313-billion-cut-in-medicaid-spending-in-trumps-big-beautiful-bill">spending cuts</a> by blocking able-bodied adults without dependent children in Medicaid expansion states from receiving the enhanced 9-to-1 Federal Medical Assistance Percentage (FMAP).
Insurers have also <a href="https://www.benzinga.com/personal-finance/tax/25/06/46012776/brace-for-higher-healthcare-premiums-in-2026-as-insurers-blame-trumps-tariffs-in-filings-to-regulators-report">warned of higher premiums</a> in 2026, placing the blame on President Donald Trump&#8217;s tariffs, which are expected to increase the cost&nbsp;of prescription drugs, medical devices,&nbsp;and other medical products and&nbsp;services.
Price Action: Shares of Centene dropped 40.37% on Wednesday, closing at $33.78, but are up 1.10% after hours.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="143" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-1024x143.png" alt="" class="wp-image-971299" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-1024x143.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-300x42.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM-768x107.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02234828/Screenshot-2025-07-03-at-9.18.15-AM.png 1532w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
According to Benzinga&#8217;s Edge Stock Rankings, Centene scores well on Value and Growth, but has an unfavorable price trend in the short, medium and long term. Click <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">here</a> for deeper insights on the stock, as well as its peers and competitors in the managed care space.
Photo courtesy: katz / Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/personal-finance/management/25/06/46166087/mark-cuban-slams-insurers-over-high-deductibles-urges-josh-hawley-to-change-the-game-with-two-part-plan">Mark Cuban Slams Insurers Over High Deductibles, Urges Josh Hawley To &#8216;Change The Game&#8217; With Two-Part Plan</a></li>
</ul>

Guidance

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

iShares Dow Jones US Health Care Provides Index Fund

Jim Cramer On Centene's 40% Crash: Fewer ACA Signups, Sicker Patients, Pulled Guidance And Major Earnings Hit Trigger Selloff: 'This Is Horrifying'

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) purist Willy Woo tied the leading cryptocurrency&#8217;s growth with global liquidity on Wednesday, stating that the more money printed, the larger it will become.
What Happened: In an X post, Woo said that out of all macro assets, Bitcoin is the &#8220;most sensitive&#8221; to global money supply. 
&#8220;Global liquidity = money printing. It&#8217;s a beautiful thing. The central banks print, the bigger BTC gets, fiat dies,&#8221; the analyst argued.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fiat is an octopus with many tentacles. It loses some tentacles but the octopus stays.
&mdash; Neo (@BITC_minimalist) <a href="https://twitter.com/BITC_minimalist/status/1940508722012606906?ref_src=twsrc%5Etfw">July 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Neo, an X user, disputed the assertions, describing fiat currency as an &#8220;octopus with many tentacles.&#8221; The counter-argument was that fiat is resilient and can withstand financial crises.
&#8220;Fiat will blow up. Fiat exists to patch government overspending. That train doesn&#8217;t last forever,&#8221; Woo responded.
See Also:&nbsp;<a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46089127/arthur-hayes-doubles-down-on-250000-bitcoin-call-sees-1-million-by-2028">Arthur Hayes Doubles Down On $250,000 Bitcoin Call — Sees $1 Million By 2028</a>
Woo&#8217;s tweet comes in the context of growing concerns over the U.S.&#8217;s national debt, which is said to exceed $175 trillion, according to Silicon Valley investor and economic commentator Balaji Srinivasan. Srinivasan recently stated that the U.S. is heading towards a national bankruptcy, with no possible solution to its debt crisis.&nbsp;<a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46213919/elon-musk-is-100-correct-says-balaji-srinivasan-america-is-broke-and-there-is-no-fix-but-is-it-a-win-win-for-bitcoin">Benzinga</a>&nbsp;reported.
Why It Matters: Woo&#8217;s views align with those of other cryptocurrency market commentators like Anthony Pompliano, who projected Bitcoin to soar due to <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46188791/anthony-pompliano-says-bitcoin-to-reach-a-gazillion-driven-by-massive-money-printing-in-a-heated-economy">massive money printing</a>.
President Donald Trump&#8217;s &#8220;Big Beautiful Bill,&#8221; which is set to cause major fiscal expansion, has led several market analysts to point to Bitcoin <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46227149/every-new-trillion-of-debt-in-trumps-big-beautiful-bill-is-free-adertising-for-bitcoin-expert-states">as a potential long-term beneficiary</a>, with every new trillion added to the debt being &#8220;free advertising&#8221; for the asset.
The U.S. economy is facing a potential crisis as the national debt,&nbsp;<a href="https://www.benzinga.com/markets/25/05/45535837/us-faces-death-by-a-thousand-cuts-as-national-debt-tops-36-trillion-cautions-deutsche-bank-the-drip-drip-drip-of-poor-fiscal-news-building-up" target="_blank" rel="noreferrer noopener">currently exceeding $36.2 trillion</a>, continues to rise, sparking concerns among economists and analysts. Silicon Valley investor Balaji Srinivasan <a href="https://www.benzinga.com/markets/macro-economic-events/25/07/46213919/elon-musk-is-100-correct-says-balaji-srinivasan-america-is-broke-and-there-is-no-fix-but-is-it-a-win-win-for-bitcoin">said that the U.S. is heading towards a national bankruptcy</a>, with no possible solution in sight.
Price Action:  At the time of writing, Bitcoin was exchanging hands at $108,804.49, up 2.55% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Photo Courtesy: Rido on Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://benzinga.com/crypto/cryptocurrency/25/07/46201788/public-companies-are-quietly-building-massive-bitcoin-treasuries-faster-than-etfs-can-keep-up" target="_blank" rel="noreferrer noopener">Public Companies Are Quietly Building Massive Bitcoin Treasuries Faster Than ETFs Can Keep Up &#8211; Benzinga</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Trading Ideas

$BTC

Bitcoin Gets 'Bigger' The More Money Central Banks Print, Says Popular Crypto Analyst: 'It's A Beautiful Thing'

Leading cryptocurrencies rallied sharply on Wednesday as institutional demand fuels optimism.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Cryptocurrency</th>
<th>Gains +/-</th>
<th>Price (Recorded at 10:20 p.m. ET)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>+3.09%</td>
<td>$108,832.24</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+6.72%</td>
<td>$2,571.03</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+6.21%</td>
<td>$0.1680</td>
</tr>
</tbody>
</table>
</figure>
What Happened: Bitcoin rallied to an intraday high of $109,763.65 in the afternoon before profit-taking dragged it back to the $108,000 region.
The upsurge followed news that BlackRock&#8217;s iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) is <a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46228970/blackrocks-bitcoin-etf-surpasses-sp-500-etf-in-revenue-as-xrp-dogecoin-etf-approval-predicted-to-follow-soon">now generating more in fees</a> than its flagship S&amp;P 500 fund.
Bitcoin's spike rubbed off on the rest of the market, with Ethereum and altcoins surging significantly.
The upsurge resulted in over $250 million in bearish short positions getting erased in the last 24 hours.&nbsp;
Bitcoin&#8217;s open interest powered 8.71% in the last 24 hours to $74 billion, indicating high speculative interest. Interestingly, over 68% of Binance traders with open BTC positions continued to be short as of this writing.
The "Greed" sentiment intensified from 63 to 73 in the last 24 hours, according to the Crypto Fear &amp; Greed Index.
Top Gainers (24 Hours)
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Cryptocurrency</th>
<th>Gains +/-</th>
<th>Price (Recorded at 10:20 p.m. ET)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bonk (BONK)</td>
<td>+19.97%</td>
<td>$0.0000164</td>
</tr>
<tr>
<td>Celestia (TIA)&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+17.82%</td>
<td>$1.61</td>
</tr>
<tr>
<td>dogwifhat (WIF)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>+16.87%</td>
<td>$0.9243 </td>
</tr>
</tbody>
</table>
</figure>
The global cryptocurrency market capitalization stood at $3.36 trillion, surging 3.49% in the last 24 hours.
Major stock averages bumped during Wednesday's trading. The S&amp;P 500 climbed &nbsp;0.47% to close at a new record high of 6,227.42. The tech-heavy Nasdaq Composite rose 0.94%, also closing at a record of 20,393.13. The Dow Jones Industrial Average was the outlier, recording a minor dip to close at 44,484.42.&nbsp;
The rally comes after Trump announced that the U.S. struck a trade <a href="https://truthsocial.com/@realDonaldTrump/posts/114784170652465525">deal </a>with Vietnam, a <a href="https://www.benzinga.com/tech/25/04/44726879/vietnam-a-hub-for-us-tech-giants-like-apple-and-nvidia-wants-to-talk-trade-after-trump-pauses-46-tariff">hub for tech giants</a> like Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)
See More: <a href="https://www.benzinga.com/money/best-crypto-scanners">Best Cryptocurrency Scanners</a>
Analyst Notes: Blockchain analytics platform Santiment said Bitcoin's rally has sparked a FOMO on social media.
"Prices move opposite to retail traders&#8217; behavior, so don&#8217;t be surprised by a brief rally halt while greed is high," Santiment added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f973; Bitcoin has jumped to $109.8K today with FOMO setting in across X, Reddit, Telegram, 4Chan, BitcoinTalk, &amp; Farcaster. Prices move opposite to retail traders&#39; behavior, so don&#39;t be surprised by a brief rally halt while greed is high. &#x1f517; Link to chart: <a href="https://t.co/Ak3ITrgSay">https://t.co/Ak3ITrgSay</a> <a href="https://t.co/nG9LcIajEo">pic.twitter.com/nG9LcIajEo</a>
&mdash; Santiment (@santimentfeed) <a href="https://twitter.com/santimentfeed/status/1940499298468442591?ref_src=twsrc%5Etfw">July 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
On the other hand, widely followed cryptocurrency analyst and trader Ali Martinez found Bitcoin's daily chart "promising."
"A daily close above $109,000 could open the door to a rally toward $118,000," the analyst predicted.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Despite the broader quarterly outlook shared in this video, the daily chart for Bitcoin <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> looks promising. A daily close above $109,000 could open the door to a rally toward $118,000! <a href="https://t.co/6v8skxXj0P">https://t.co/6v8skxXj0P</a> <a href="https://t.co/Ohqh3THBIm">pic.twitter.com/Ohqh3THBIm</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1940454912779047034?ref_src=twsrc%5Etfw">July 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Photo: Antonio Gravante On Shutterstock.com
Read Next:&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/07/46215827/bitcoins-halving-cycle-is-over-standard-chartered-affirms-what-that-means-for-you">Bitcoin&#8217;s Halving Cycle Is &#8216;Over&#8217;, Standard Chartered Affirms: What That Means For You</a></li>
</ul>

Movers

$DOGE

$ETH

AAPL

IBIT

NVDA

Bitcoin Nearly Hits $110,000 — Ethereum, Dogecoin Also Spike Amid ETF Buzz: Analyst Says Door Open For $118,000 BTC Rally

Editor's Note: This article has been revised to provide accurate details regarding Oracle's stock activity. U.S. stocks experienced a surge on Wednesday, with the S&amp;P 500 <a href="https://www.benzinga.com/markets/equities/25/07/46228695/wall-street-today-sp500-bitcoin-price-trump-vietnam">setting new record highs</a> following a surprising decline in private payrolls, which bolstered expectations of Federal Reserve rate cuts. The S&amp;P 500 soared above 6,200 points, marking new record highs. The index gained 0.5% for the day. The Nasdaq also rose by 0.9% to 22,393.13. Meanwhile, the Dow Jones Industrial Average held steady around 44,500.
These are the top stocks that gained the attention of retail traders and investors throughout the day:
BigBear.ai Holdings, Inc.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBAI#NYSE">BBAI</a>)
BigBear.ai stock rallied by 13.68% to close at $7.56. The stock hit an intraday high of $7.85 and a low of $6.50. The 52-week high and low are $10.36 and $1.16. The stock&#8217;s significant and rapid rally over the past week could indicate a potential&nbsp;<a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46231599/stock-of-the-day-short-squeeze-in-bigbear-ai">short squeeze</a>.
Rigetti Computing&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>)
Rigetti Computing stock soared by 15.45% to close at $13.08. The stock reached an intraday high of $13.10 and a low of $11.43. The 52-week high and low are $21.42 and $0.66. The quantum computing firm has seen its stock surge more than 1,000% over the past year, attracting&nbsp;<a href="https://www.benzinga.com/analyst-stock-ratings/initiation/25/07/46230597/quantum-computings-dark-horse-rigetti-stands-at-the-edge-of-greatness">Wall Street&#8217;s attention</a>.
Datadog Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>)
Datadog stock rose by 2.03% to close at $135.01. The stock hit an intraday high of $135.39 and a low of $131. The 52-week high and low are $170.08 and $81.65. The stock surged after the announcement of the company&#8217;s&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/25/07/46236303/datadog-stock-surges-on-sp-500-inclusion">inclusion in the S&amp;P 500</a>.
Oracle Corporation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>)
Oracle stock increased by 5.03% to close at $229.98. The stock reached an intraday high of $231.90 and a low of $216.72. The 52-week high and low are $231.90 and $118.86. Oracle shares <a href="https://www.benzinga.com/trading-ideas/movers/25/06/46171946/oracle-stock-hits-all-time-high-after-ceo-flags-strong-start-to-fiscal-2026">hit new highs</a> on Monday after CEO Safra Catz said in an SEC filing that fiscal 2026 was off to a strong start, with MultiCloud database revenue growing over 100%. Analysts, including Stifel, UBS, and Guggenheim, raised their price targets to $250, boosting investor confidence.
Tesla Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla stock climbed by 4.97% to close at $315.65. The stock hit an intraday high of $316.83 and a low of $303.82. The 52-week high and low are $488.54 and $182. Amid declining sales, the Elon Musk-led company confirmed the&nbsp;<a href="https://www.benzinga.com/markets/tech/25/07/46212911/amid-declining-sales-elon-musks-tesla-confirms-new-affordable-models-will-be-introduced-this-year">introduction of more affordable models</a>&nbsp;to its lineup. &#8220;The accessibility of our products is fundamental to our mission,&#8221; said the company in a report.
Benzinga&#8217;s Edge Stock Rankings indicate BigBear.ai checks out on Short, Medium and Long Price Trends. Here is how the stock fares on <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">other parameters</a>.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="446" height="283" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02215931/Screenshot-2025-07-03-at-10.59.11.png" alt="" class="wp-image-971219" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02215931/Screenshot-2025-07-03-at-10.59.11.png 446w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/02215931/Screenshot-2025-07-03-at-10.59.11-300x190.png 300w" sizes="(max-width: 446px) 100vw, 446px" /></a></figure>
Prepare for the day&#8217;s trading&nbsp;<a href="https://editorial.benzinga.com/wp-admin/Premarket%20Movers%20&amp;%20News">with top premarket movers and news</a>&nbsp;by Benzinga.
Photo Courtesy: Who is Danny on Shutterstock.com
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://benzinga.com/markets/equities/25/06/46186520/bernie-sanders-warns-of-concentration-of-ownership-in-us-companies-thats-power" target="_blank" rel="noreferrer noopener">Bernie Sanders Warns Of &#8216;Concentration of Ownership&#8217; In US Companies: &#8216;That&#8217;s Power&#8217;</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

BBAI

ORCL

RGTI

BigBear.Ai, Rigetti Computing, Datadog, Oracle, And Tesla: Why These 5 Stocks Are On Investors' Radars Today (CORRECTED)

With Zohran Mamdani officially securing the <a href="https://www.benzinga.com/news/politics/25/06/46087359/zohran-mamdani-leads-nyc-mayoral-primary-andrew-cuomo-concedes-race">Democratic nomination</a> in the New York City mayoral race, centrist figures within the Democratic party, such as former Treasury Secretary Jack Lew, are raising questions on the city&#8217;s future under a self-described Democratic Socialist.
What Happened: Appearing on The Master Investor podcast on Wednesday, Lew, who served in the Obama and Clinton administrations and was most recently U.S. ambassador to Israel under President Joe Biden, offered a sharp rebuke on Mamdani's policy platform.
He says, &#8220;I worry deeply,&#8221; calling New York City his home, where he&#8217;s spent most of his life, while adding that the policies outlined by Mamdani are not good for the city.
See Also: <a href="https://www.benzinga.com/news/topics/25/07/46201600/bernie-sanders-declares-its-citizens-versus-billionaire-donors-as-bill-ackman-and-co-open-their-wallets-to-take-down-zohran-mamdani">Bernie Sanders Declares It&#8217;s Citizens Versus Billionaire Donors As Bill Ackman And Co. Open Their Wallets To Take Down Zohran Mamdani</a>
Lew suggests that he views Mamdani&#8217;s policies as impractical, drawing parallels between both far-left and far-right proposals. He says, populist policies from either side often skip a critical test, &#8220;[They] don't always go through the filter of, do they work? I don't think they work.&#8221;
He also noted that New York's mayoral powers are constrained. &#8220;New York is not an entirely independent governing entity. Many of the policies have to be approved by the state legislature or governor,&#8221; Lew said, suggesting that institutional checks may blunt the impact of any sweeping ideological shift.
Why It Matters: Last week, billionaire hedge fund manager Bill Ackman echoed similar views, expressing &#8220;grave concern&#8221; on Mamdani&#8217;s victory. 
The CEO of Pershing Square Capital Management warned that Mamdani, an &#8220;avowed socialist,&#8221; would be &#8220;disastrous for NYC,&#8221; <a href="https://www.benzinga.com/news/politics/25/06/46108561/bill-ackman-rips-chuck-schumer-over-zohran-mamdani-praise-calls-it-pathetic-warns-nyc-risks-10-billion-in-lost-wealth">triggering an exodus</a> of wealthy taxpayers, resulting in a $5 billion to $10 billion drop in the city&#8217;s revenues from the financial services industry alone.
<figure class="wp-block-embed aligncenter is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I awoke this morning gravely concerned about New York City. I thought "What has NYC become that an avowed socialist who has supported defunding the police, whose solution to lowering food prices is city-owned supermarkets, who doesn't understand that freezing rents will only…
&mdash; Bill Ackman (@BillAckman) <a href="https://twitter.com/BillAckman/status/1938094628034506984?ref_src=twsrc%5Etfw">June 26, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Cameron Winklevoss, co-founder of cryptocurrency exchange&nbsp;Gemini, commented on Mamdani&#8217;s victory last week, saying, &#8220;It appears things will have to get worse in NYC before they get better,&#8221; adding that sometimes the only way to learn something &#8220;is to learn it the hard way.&#8221;
&#8220;It's what the people of NYC have been asking for for years and it looks like it's what they are about to get. Trying to fight against this tide seems like throwing good money after bad,&#8221; he says, while <a href="https://www.benzinga.com/news/politics/25/06/46108180/no-point-fighting-against-the-tide-by-opposing-zohran-mamdani-says-gemini-co-founder-cameron-winklevoss-things-will-have-to-get-worse-in-nyc-before-they-get-better">expressing his reluctance</a> to support a candidate against Mamdani.
Image via Ron Adar on Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/06/46162859/trump-threatens-to-cut-federal-funding-for-nyc-if-zohran-mamdani-doesnt-do-the-right-thing-as-future-mayor-if-he-does-get-in-im-going-to-be-president">Trump Threatens To Cut Federal Funding For NYC If Zohran Mamdani Doesn&#8217;t Do The &#8216;Right Thing&#8217; As Future Mayor: &#8216;If He Does Get In, I&#8217;m Going To Be President&#8230;&#8217;</a></li>
</ul>

Ex-Obama Treasury Secretary Jack Lew Sounds Alarm On NYC Under Zohran Mamdani: 'I Worry Deeply'

Press Releases

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Quanterix Releases Financial Results for the First Quarter of 2025

Small Cap

Opinion

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

AKOYA BIOSCIENCES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

Comments

Quanterix

Notizie

Ultime notizie per Quanterix (NASDAQ:QTRX) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO